Alnylam Pharmaceuticals (ALNY) Earnings Date, Estimates & Call Transcripts $240.01 +2.24 (+0.94%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Alnylam Pharmaceuticals Earnings Summary Upcoming Earnings DateMay. 1Before Market OpensEstimatedConsensus EPS (Feb. 13) -$0.62 Actual EPS (Feb. 13) -$0.65 Missed By -$0.03 Alnylam Pharmaceuticals released Q4 2024 earnings on February 13, 2025, reporting an EPS of -$0.65, which missed the consensus estimate of -$0.62 by $0.03. With a trailing EPS of -$2.17, Alnylam Pharmaceuticals' earnings are expected to grow next year, from ($1.70) to $0.89 per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings ReportConference Call Transcript & Audio Annual Report (10-K) Slide Deck Press Release (8-K)SEC FilingALNY Upcoming EarningsAlnylam Pharmaceuticals' Q1 2025 earnings is scheduled for Thursday, May 1, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportSlide DeckFull Screen Slide DeckPowered by Get Alnylam Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alnylam Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataALNY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ALNY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Alnylam Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$1.00-$0.67-$0.79Q2 20253-$1.02-$0.61-$0.79Q3 20254-$0.48$0.15-$0.31Q4 20254-$0.42$1.38$0.22FY 202515-$2.92$0.25-$1.68Q1 20261-$0.05-$0.05-$0.05Q2 20261-$0.15-$0.15-$0.15Q3 20261$0.07$0.07$0.07Q4 20261-$0.08-$0.08-$0.08FY 20264($0.21)($0.21)($0.21) Remove Ads Alnylam Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/1/2025(Estimated)-------2/13/2025Q4 2024-$0.62-$0.65 -$0.03-$0.65$580.62M-10/31/2024Q3 2024-$0.51-$0.87 -$0.36-$0.87$532.91M$500.90M8/1/2024Q2 2024-$0.74-$0.13+$0.61-$0.13$447.22M$659.83M5/2/2024Q1 2024-$0.75-$0.52+$0.23-$0.52$428.01M$494.33M2/15/2024Q4 2023-$1.20-$1.10+$0.10-$1.10$439.38M$439.72M11/2/2023Q3 2023-$1.61$1.15+$2.76$1.15$406.14M$750.53M8/3/2023Q2 2023-$1.72-$2.21 -$0.49-$2.21$331.73M$318.75M5/4/2023Q1 2023-$1.97-$1.40+$0.57-$1.40$312.53M$319.29M Alnylam Pharmaceuticals Earnings - Frequently Asked Questions When is Alnylam Pharmaceuticals's earnings date? Alnylam Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 1st, 2025 based off last year's report dates. Learn more on ALNY's earnings history. What guidance has Alnylam Pharmaceuticals issued on next quarter's earnings? Alnylam Pharmaceuticals updated its FY 2025 earnings guidance on Thursday, February, 13th. The company issued revenue guidance of $2.7 billion-$3.0 billion, compared to the consensus revenue estimate of $2.7 billion. Did Alnylam Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Alnylam Pharmaceuticals (NASDAQ:ALNY) missed the analysts' consensus estimate of ($0.62) by $0.03 with a reported earnings per share (EPS) of ($0.65). Learn more on analysts' earnings estimate vs. ALNY's actual earnings. How can I listen to Alnylam Pharmaceuticals's earnings conference call? The conference call for Alnylam Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Alnylam Pharmaceuticals's conference call transcript? The conference call transcript for Alnylam Pharmaceuticals's latest earnings report can be read online. Read Transcript How can I view Alnylam Pharmaceuticals's earnings report? Alnylam Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Alnylam Pharmaceuticals generate each year? Alnylam Pharmaceuticals (NASDAQ:ALNY) has a recorded annual revenue of $2.25 billion. How much profit does Alnylam Pharmaceuticals generate each year? Alnylam Pharmaceuticals (NASDAQ:ALNY) has a recorded net income of -$278.16 million. ALNY has generated -$2.17 earnings per share over the last four quarters. What is Alnylam Pharmaceuticals's EPS forecast for next year? Alnylam Pharmaceuticals's earnings are expected to grow from ($1.70) per share to $0.89 per share in the next year. More Earnings Resources from MarketBeat Related Companies Regeneron Pharmaceuticals Earnings Date Biogen Earnings Date United Therapeutics Earnings Date Incyte Earnings Date BioMarin Pharmaceutical Earnings Date Exelixis Earnings Date Neurocrine Biosciences Earnings Date Exact Sciences Earnings Date Halozyme Therapeutics Earnings Date Madrigal Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside? Remove Ads This page (NASDAQ:ALNY) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alnylam Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALNY Stock Free ALNY Stock Alerts